Press & media
Swedish innovation recognised in the UK- offsets the need for reflux medication and surgery
IQoro is a neuromuscular treatment and product for reflux and swallowing difficulties, which can offset the need for medication and surgery according to National Health Service innovation organisations in the UK. The Swedish innovation IQoro has been awarded the prestigious “Product of the Year” award at the Bionow Awards. The Bionow Awards is one of […]
Read moreIQoro shortlisted for Bionow Product of the Year Award
We are very proud to tell you that IQoro has been shortlisted in the category “Product of the Year” at the prestigious Bionow Awards that will be held in Manchester on March 7, 2024. The event is a highlight of the life sciences calendar and celebrates the achievements of the sector, showcasing the very best […]
Read moreMYoroface named one of the fastest growing companies in Europe
MYoroface, the Swedish healthtech company behind the IQoro, has been named one of the fastest growing companies in Europe. The award comes from the annual FT 1000 report developed by The Financial Times, which ranks European companies that have achieved the highest growth in recent years. In the UK, around 13 million people suffer from […]
Read morePress contact
Linn Hägg
004670-344 89 55
linn.hagg@myoroface.com